# A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants

> **NCT05320302** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 6 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** [11C]-Lu AF88370

## Key facts

- **NCT ID:** NCT05320302
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-31
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-20
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05320302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05320302, "A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05320302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*